Goldman Sachs analyst Andrew Baker upgraded AXA (AXAHY) to Buy from Neutral with a EUR 44 price target The shares have underperformed over the past 12 months despite AXA executing well against the first year of its planning targets and having a business mix that has more of a retail bias than the headline numbers suggest, the analyst tells investors in a research note. The firm says the company’s 2025 growth momentum remains strong.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXAHY: